Vitarka Therapeutics appoints Dr John Beadle as Chairman of the Board
London, 27 November 2024: Vitarka Therapeutics Ltd, the EndoPore® cancer [...]
London, 27 November 2024: Vitarka Therapeutics Ltd, the EndoPore® cancer [...]
Many thanks to everyone who took the time to enter [...]
Jim Faulkner, NED of Vitarka TherapeuticsVitarka Therapeutics Ltd, a preclinical [...]
Congratulations to the winners and runner-ups of our very first [...]
Welcome to the third annual SOSV Human Health 100. The [...]
Seventeen new projects will receive funding for cutting edge medicine [...]
A female-led preclinical biotech start-up Vitarka Therapeutics, focused on revolutionising [...]
Do investors scrutinize CEOs more closely when they are women? [...]
IBNY05’s In-Person Preview will take place on Feb 1, [...]
Dr Vineeta Tripathi is the founder of Vitarka Theraputics, [...]